SHPH Q2 2025 Earnings — Shuttle Pharmaceuticals Holdings, Inc. Revenue & Financial Results | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

$1M

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-3.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$46,853

Balance Sheet

Total Assets

$6M

Total Liabilities

$2M

Stockholders' Equity

$4M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$1M	-163.7%
Net Income	-$4M	-$2M	-82.5%